Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised the arranging banks in connection with Svenska Handelsbanken’s issue of Additional Tier 1 Capital Contingent Convertible (AT1) in the amount of MUSD 1000
Mandate

Vinge has advised the arranging banks in connection with Svenska Handelsbanken’s issue of Additional Tier 1 Capital Contingent Convertible (AT1) in the amount of MUSD 1000 

October 07, 2020 Banking and Finance

Vinge has advised Morgan Stanley & Co. International plc and the other arranging banks consisting of Barclays Bank PLC, Citigroup Global Markets Limited, J.P. Morgan Securities plc and Svenska Handelsbanken AB (publ) in respect of Swedish law in connection with Svenska Handelsbanken’s issue of Additional Tier 1 Contingent Convertible Notes (AT1 CoCo). The issuance amount is USD 1,000 million in two tranches of USD 500 million each, at interest rates of 4.375 and 4.75 per cent respectively.

The loans are perpetual without a final maturity date but the Bank has the option to redeem the loans after 6.5 years (March 2027) and 10.5 years (March 2031), and then subsequently every fifth year. The issuance of AT1 is in the form of debt instruments with automatic conversion to class A-shares, if the Bank’s common equity tier 1 ratio (CET1) falls below a certain level.
The issuance of additional AT1 capital is part of the bank’s capital planning.
The issuance was subscribed by and allotted to the joint lead managers on 6 October 2020 and have been listed on the Global Exchange Market of Euronext Dublin.
Vinge’s team consisted of responsible partner Mikael Ståhl, Paulina Malmberg and Malte St Cyr Ohm. 

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025